VeriMomVeriMom

¿Es pentapeptide-61 seguro durante el embarazo?

No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.

Ingredientes
pentapeptide-61
SIN RIESGOS CONOCIDOS
100
/100
0

Related ingredients

Frequently asked questions

¿Es pentapeptide-61 seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for pentapeptide-61 was identified in available regulatory sources. No peer-reviewed reproductive or developmental toxicity data specific to pentapeptide-61 were found. Peptides of this size are generally polar and have low systemic absorption after topical use, so default hazard/mechanism/exposure ratings are 0. Sources consulted: ECHA Annex VI (no entry), CIR (no specific assessment), PubMed (no reproductive/developmental studies found), CosIng/PubChem entries show cosmetic peptide identity only.
¿Es pentapeptide-61 seguro durante la lactancia?
No evidence of reproductive or lactation-specific toxicity or mechanism for pentapeptide-61 in SCCS/CIR/ECHA or peer-reviewed literature. No harmonised classification. Given expected low dermal absorption of short peptides, systemic exposure to lactating parent and transfer into breast milk is considered negligible based on available information.
¿Es pentapeptide-61 seguro para la piel del bebé?
No infant-specific safety or developmental toxicity data identified. Peptides this size are generally poorly absorbed through intact adult skin (adult exposure rated 0), but infant skin has higher permeability; following guidance, exposure for baby skin is increased by +1 (to 1) due to possible measurable absorption in infants. No mechanistic or hazard evidence for reproductive/developmental effects specific to infants was found.
¿Cómo puntúa VeriMom a pentapeptide-61?
VeriMom puntúa pentapeptide-61 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
¿Cuáles son las alternativas seguras a pentapeptide-61 en el embarazo?
Consulta nuestra lista de alternativas seguras a pentapeptide-61 según función similar y clasificación sin riesgos conocidos.

Comprueba cualquier etiqueta en 2 segundos

Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.

Aviso Médico

Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.

Obtén la experiencia completa en la app VeriMom